Coswig, Germany Clinical Trials — 11 Studies

Filter these 11 trials by phase, condition, sponsor and more.

Open in Search →

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 5 2024-07-15 Progressive Pulmonary Fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 5 2024-06-24 Idiopathic pulmonary fibrosis
A study to find out whether BI 765423 has an effect on lung function in people with idiopathic pulmonary fibrosis (IPF) with or without stan … Recruiting

2025-520658-12-00 4 2025-11-20 Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 5 2025-04-07 Progressive Pulmonary Fibrosis
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting

2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended recruitment

2023-504471-25-00 5 2024-03-01 Fibrotic Lung Disease
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastati … Ended

2023-506882-70-00 5 2024-08-16 Non-small-cell lung cancer
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the tr … Ended

2023-506185-31-00 10 2024-07-18 Idiopathic pulmonary fibrosis (IPF)
A study of efficacy and safety of various treatments in participants with idiopathic pulmonary fibrosis (IPF) Ended

2023-508729-28-00 4 2023-04-25 Idiopathic pulmonary fibrosis
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Ended

2024-514761-19-00 5 2023-01-25 Idiopathic Pulmonary Fibrosis
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 5 2022-10-05 Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Showing 1–11 of 11 trials